Accelerating global antibacterial innovation Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world. The CARB-X portfolio is the world’s most scientifically diverse, early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products. CARB-X is the only… Continue reading The second cycle of the 2024 @CARB_X funding round opens on 23-Sep-24

Chiratae Ventures, a leading Indian venture capital firm, has announced the launch of the 2024 cohort of its flagship seed investment initiative, Chiratae Sonic. This program, known for its rapid decision-making and streamlined investment process, aims to accelerate the growth of early-stage tech startups. Building on the success of previous editions, Chiratae Sonic continues to… Continue reading VC Fund Chiratae Ventures Launches 2024 Sonic Program to Boost Early-Stage Indian Tech Startups